• Globe Newswire

Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics

Globenewswire -

• Globe Newswire

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

Globenewswire -

• Globe Newswire

Pow.Bio Unveils State-of-the-Art Facility in Alameda, Expanding Biomanufacturing Capabilities to Support Demand for Continuous Fermentation

Globenewswire -

• Globe Newswire

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Globenewswire -

• Globe Newswire

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

Globenewswire -

• Globe Newswire

Winners in First Annual Stevie® Awards for Technology Excellence Announced

• Globe Newswire

Olon Group Announces the Acquisition of GTP Bioways Group